Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (161-170 of 504) with videos related to

Pageof 51
Sort By:
Cancer Biology & Therapy|January 17, 2004
Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitizationFrank Tacke, Frank C Marini, Shourong Zhao, et al.
Cancer Research|November 19, 2009
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomasRaymund L Yong, Naoki Shinojima, Juan Fueyo, et al.
Blood|January 12, 2008
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5Bing Z Carter, Duncan H Mak, Wendy D Schober, et al.
JCI Insight|March 1, 2022
In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individualsLi Li, Muharrem Muftuoglu, Shaoheng Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Loss of expression of both miR-15/16 loci in CML transition to blast crisisFrancesca Lovat, Pierluigi Gasparini, Giovanni Nigita, et al.
Molecular Cancer Therapeutics|September 22, 2018
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling PathwayKhoa Nguyen, Yuanqing Yan, Bin Yuan, et al.
Stem Cells (Dayton, Ohio)|August 4, 2009
Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imagingShannon Kidd, Erika Spaeth, Jennifer L Dembinski, et al.
Cancer|April 17, 2014
Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutationsYesid Alvarado, Hagop M Kantarjian, Rajyalakshmi Luthra, et al.
Haematologica|February 2, 2023
Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures <i>NPM1/FLT3</i>-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft modelBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Cell Cycle (Georgetown, Tex.)|September 14, 2006
Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistanceBing Z Carter, Duncan H Mak, Yuexi Shi, et al.
Pageof 51

Showing results (161-170 of 504) with videos related to

Sort By:
Pageof 51
Cancer Biology & Therapy|January 17, 2004
Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitizationFrank Tacke, Frank C Marini, Shourong Zhao, et al.
Cancer Research|November 19, 2009
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomasRaymund L Yong, Naoki Shinojima, Juan Fueyo, et al.
Blood|January 12, 2008
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5Bing Z Carter, Duncan H Mak, Wendy D Schober, et al.
JCI Insight|March 1, 2022
In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individualsLi Li, Muharrem Muftuoglu, Shaoheng Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Loss of expression of both miR-15/16 loci in CML transition to blast crisisFrancesca Lovat, Pierluigi Gasparini, Giovanni Nigita, et al.
Molecular Cancer Therapeutics|September 22, 2018
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling PathwayKhoa Nguyen, Yuanqing Yan, Bin Yuan, et al.
Stem Cells (Dayton, Ohio)|August 4, 2009
Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imagingShannon Kidd, Erika Spaeth, Jennifer L Dembinski, et al.
Cancer|April 17, 2014
Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutationsYesid Alvarado, Hagop M Kantarjian, Rajyalakshmi Luthra, et al.
Haematologica|February 2, 2023
Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures <i>NPM1/FLT3</i>-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft modelBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Cell Cycle (Georgetown, Tex.)|September 14, 2006
Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML: overcoming imatinib resistanceBing Z Carter, Duncan H Mak, Yuexi Shi, et al.
Pageof 51